SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial (RILY) is trending after filing its Q3 financial results, showcasing renewed profitability and NASDAQ compliance. This development has ignited intense community discussion around a potential short and gamma squeeze, with many comparing it to past explosive market events due to high short interest and a constrained float.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is trending after securing approval for an additional 830 megawatts at its Helios Data Center Campus, doubling its total power capacity to over 1.6 Gigawatts. The community is hailing this as a game-changing development, significantly re-rating GLXY's valuation as a key hybrid player in both the institutional crypto market and the burgeoning AI infrastructure sector.

Springview Holdings Ltd. engages in the design and construction of residential and commercial buildings. It involves new construction, reconstruction, alterations, and other general contracting services. The company was founded in 2002 and is headquartered in Singapore.

Springview Holdings Ltd - Ordinary Shares - Class A

Springview Holdings Ltd

Springview Holdings (SPHL) is experiencing intense investor interest driven by a newly announced strategic partnership for solar and green-energy solutions in Singapore. The community is actively discussing the stock's extremely low float, fueling speculation about significant short squeeze potential and prompting expectations of highly volatile price action. While many anticipate a substantial upward move, a segment of traders urges caution, referencing the ticker's history of sharp price fluctuations.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies (BMNR) is actively discussed after its substantial $200 million investment in Beast Industries, founded by YouTube star MrBeast. This strategic pivot has sparked intense debate among investors, with many questioning the allocation of capital away from core Ethereum holdings and share buybacks. Others view it as a forward-thinking move to attract younger demographics and expand into future crypto-backed ventures, further fueling community discussion around an upcoming vote on a significant increase in authorized shares.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor Manufacturing is trending strongly after delivering an impressive earnings report that surpassed expectations, fueled by robust demand for advanced AI chips. The semiconductor giant's optimistic guidance and substantial capital expenditure plans are widely viewed by the community as a powerful affirmation of the accelerating AI infrastructure build-out. This performance is boosting sentiment across the broader semiconductor sector and reinforcing confidence in the long-term AI megatrend.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical ($DRTS) is trending amidst high anticipation for imminent Japanese regulatory approval and a key presentation at a major healthcare conference this week, further bolstered by recent compelling pancreatic cancer data. The community is actively discussing the stock's pioneering Alpha DaRT technology and its life-saving potential in difficult-to-treat cancers, believing it remains significantly undervalued as it garners increasing institutional interest and ETF attention.

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Cns Pharmaceuticals Inc

CNSP is trending due to its recent Orphan Drug designation for TPI-287, a treatment for brain cancer, sparking excitement around potential upside. The community is actively discussing the stock's low float and potential for a squeeze, with some analysts targeting significantly higher prices. Despite a history of reverse stock splits, the focus remains on the potential of CNSP's glioblastoma pipeline.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novavax (NVAX) Moves 11.9% Higher: Will This Strength Last?

Novavax (NVAX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Ocugen (NASDAQ:OCGN) Shares Up 9% - Time to Buy?

Ocugen (NASDAQ:OCGN) Trading 9% Higher - Should You Buy...

<ul class="summary-bullets"><li>Ocugen stated that, in six patients with gradable Fundus Auto Fluorescence images, atrophic lesion growth was reduced by 54% in eyes treated with its therapy compared to untreated eyes.</li><li>The company added that lesion expansion was 50% slower in treated eyes than in eyes that did not receive treatment.</li><li>Ocugen also reported that every eye treated with its therapy showed either stabilization or improvement in visual acuity.</li></ul>Ocugen Inc. (OCGN) shares rose nearly 3% pre-market on Monday after the company announced results in its gene therapy trial for Stargardt patients with no options.Ocugen announced positive Phase 1 GARDian1 trial results for OCU410ST, its novel modifier gene therapy for Stargardt disease. This disease is a form of inherited macular degeneration, affecting more than 100,000 people in the U.S. and Europe combined, the company said.<h2 class="st-heading-2">Ocugen Trial Update</h2>In its Phase 1 GARDian1 trial update, Ocugen reported that, among six patients with gradable Fundus Auto Fluorescence images, atrophic lesion growth was reduced by 54% in eyes treated with its therapy compared to untreated eyes.The company added that lesion expansion was 50% slower in treated eyes compared to those that did not receive the treatment. Ocugen also reported that every eye treated with its therapy showed either stabilization or improvement in visual acuity.Lastly, the company stated that there were no drug-related serious adverse events, nor were adverse events of special interest observed.<h2 class="st-heading-2">Retail Upbeat</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/OCGN">Ocugen</a> edged up over the past 24 hours, hovering in the ‘bullish’ territory at the time of writing, while message volume was at ‘high’ levels.One bullish user stated that traders were not as excited about Ocugen as they should be.<stembedurl>https://stocktwits.com/HandsomeBull1/message/641502007</stembedurl><a href="https://stocktwits.com/symbol/OCGN">OCGN stock</a> is up 11% year-to-date and 81% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/abvx-soars-pre-market-on-reports-of-17-5-billion-eli-lilly-takeover-interest/cmU9zJNR4E2">ABVX Soars Pre-Market On Reports Of $17.5 Billion Eli Lilly Takeover Interest</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

OCGN Stock Rises Pre-Market After Gene Therapy Data Shows Promise In Rare Eye Disorder

Stargardt disease is a form of inherited macular degeneration, affecting more than 100,000 people in the U.S. and Europe combined.

Equity

Ocugen Stock Surges 75% Year to Date: What's in Store for 2026?

Ocugen rises 75% YTD as it advances three gene therapies, with multiple phase II/III readouts and filings lined up for 2026.

Ocugen Sees Unusually High Options Volume (NASDAQ:OCGN)

Ocugen, Inc. (NASDAQ:OCGN - Get Free Report) was the recipient of some unusual options trading activity on Friday. Stock traders bought 6,390 call options on the stock. This represents an increase of...

5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026

MindMed and four other biotech disruptors face pivotal studies and FDA decisions in 2026, setting up high-risk, high-reward opportunities for bold investors

What is HC Wainwright's Estimate for Ocugen FY2025 Earnings?

Ocugen, Inc. (NASDAQ:OCGN - Free Report) - Analysts at HC Wainwright decreased their FY2025 earnings estimates for shares of Ocugen in a research note issued on Thursday, November 6th. HC Wainwright...

Y Intercept Hong Kong Ltd Makes New Investment in Ocugen, Inc. $OCGN

Y Intercept Hong Kong Ltd purchased a new stake in shares of Ocugen, Inc. (NASDAQ:OCGN - Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange...

Ocugen (NASDAQ:OCGN) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Ocugen (NASDAQ:OCGN - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.01). The firm...

Ocugen (OCGN) Reports Q3 Loss, Beats Revenue Estimates

Ocugen (OCGN) delivered earnings and revenue surprises of -16.67% and +46.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Ocugen Inc

44th Annual J.P. Morgan Healthcare Conference

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

OCGN
Ocugen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OCGN News

OCGNOcugen Inc